HAMI 3379 (HAMI3379) is a selective cysteinyl leukotriene receptor 2 (CysLT2) antagonist that dose- and time-dependently attenuates brain damage and inhibits microglial cell inflammation following focal cerebral ischemia in rats and attenuates ischemia-like neuronal damage by inhibiting microglial activation.
Molecular Weight:
595.72
Purity:
99.75%
CAS Number:
[1245653-57-9]
Formula:
C34H45NO8
Target:
LTR|||Leukotriene Receptor
T64205
T64205
* VAT and and shipping costs not included. Errors and price changes excepted